In a new op-ed for MedCity News, ACSH s Dr. Josh Bloom tackles another important medical issue: the signing of the new Prescription Drug User Fee Act (PDUFA). The law, originally passed in 1992, allows the Food and Drug Administration (FDA) to collect fees from pharmaceutical companies in order to fund (and help expedite) the drug approval process. PDUFA must be renewed every five years. Congress just passed the new bill (almost unanimously), and it must now be signed by the President.
Read his op-ed in full here.